I. Rosa

发表

Therapeutic Advances in Musculoskeletal Disease

N. Barbarroja, E. Collantes-Estévez, C. López-Pedrera, 2019 .

THU0218 Circulating micrornas as biomarkers for diagnosis and typifying the atherothrombotic status in antiphospholipid syndrome

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2017 .

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues

N. Barbarroja, M. Malagón, A. Vidal-Puig, 2018, Journal of internal medicine.

Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.

N. Barbarroja, P. Ruiz-Limón, J. González-Reyes, 2017, Journal of autoimmunity.

CAN ARTIFICIAL INTELLIGENCE REPLACE MANUAL SEARCH FOR SYSTEMATIC LITERATURE REVIEW ON CUTANEOUS MANIFESTATIONS IN PRIMARY SJÖGREN ’ S SYNDROME?

V. Devauchelle-Pensec, P. Redou, C. López-Pedrera, 2020 .

FRI0429 Dysregulation of the splicing machinery in leukocytes from ankylosing spondylitis patients is associated to disease pathogenesis

N. Barbarroja, P. Ruiz-Limón, P. Giannoudis, 2017 .